MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
4.430
-0.160
-3.49%
After Hours: 4.430 0 0.00% 16:10 02/13 EST
OPEN
4.600
PREV CLOSE
4.590
HIGH
4.600
LOW
4.380
VOLUME
25.76K
TURNOVER
--
52 WEEK HIGH
5.12
52 WEEK LOW
2.300
MARKET CAP
73.69M
P/E (TTM)
-1.4873
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)
TipRanks · 16h ago
Craig-Hallum Reaffirms Their Buy Rating on PolyPid (PYPD)
TipRanks · 1d ago
PolyPid Earnings Call Flags Big 2026 Catalyst
TipRanks · 2d ago
Polypid targets rolling NDA submission for D-PLEX100 by end of Q1 2026 amid advanced U.S. partnership talks
Seeking Alpha · 2d ago
PolyPid Price Target Maintained With a $13.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Reiterates Buy on PolyPid, Maintains $13 Price Target
Benzinga · 2d ago
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
TipRanks · 2d ago
Israel's PolyPid Q4 EPS improves on lower R&D expenses 
Reuters · 2d ago
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.